BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Majumder J, Minko T. Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery. Expert Opin Drug Deliv 2021;18:205-27. [PMID: 32969740 DOI: 10.1080/17425247.2021.1828339] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
Number Citing Articles
1 Li M, Yu B, Wang S, Zhou F, Cui J, Su J. Microenvironment-responsive nanocarriers for targeted bone disease therapy. Nano Today 2023;50:101838. [DOI: 10.1016/j.nantod.2023.101838] [Reference Citation Analysis]
2 Pillarisetti S, Vijayan V, Rangasamy J, Bardhan R, Uthaman S, Park I. A Multi-Stimuli Responsive Alginate Nanogel for Anticancer Chemo-Photodynamic Therapy. Journal of Industrial and Engineering Chemistry 2023. [DOI: 10.1016/j.jiec.2023.03.053] [Reference Citation Analysis]
3 Zhao N, Sun Q, Zhang L, Jin H, Zhang M, Liu S, Xin H. Fe(3)O(4) Composite Superparticles with RGD/Magnetic Dual-Targeting Capabilities for the Imaging and Treatment of Non-Small Cell Lung Cancer. ACS Omega 2023;8:7891-903. [PMID: 36873026 DOI: 10.1021/acsomega.2c07647] [Reference Citation Analysis]
4 Pawar V, Maske P, Khan A, Ghosh A, Keshari R, Bhatt M, Srivastava R. Responsive Nanostructure for Targeted Drug Delivery. JNT 2023;4:55-85. [DOI: 10.3390/jnt4010004] [Reference Citation Analysis]
5 Luo W, Bai L, Zhang J, Li Z, Liu Y, Tang X, Xia P, Xu M, Shi A, Xiao L, Zhang D, Yu P. Polysaccharides-based nanocarriers enhance the anti-inflammatory effect of curcumin. Carbohydrate Polymers 2023. [DOI: 10.1016/j.carbpol.2023.120718] [Reference Citation Analysis]
6 Gao Y, Wang K, Zhang J, Duan X, Sun Q, Men K. Multifunctional nanoparticle for cancer therapy. MedComm (2020) 2023;4:e187. [PMID: 36654533 DOI: 10.1002/mco2.187] [Reference Citation Analysis]
7 Pozharov VP, Minko T. Nanotechnology-Based RNA Vaccines: Fundamentals, Advantages and Challenges. Pharmaceutics 2023;15. [PMID: 36678823 DOI: 10.3390/pharmaceutics15010194] [Reference Citation Analysis]
8 Rana A, Adhikary M, Singh PK, Das BC, Bhatnagar S. "Smart" drug delivery: A window to future of translational medicine. Front Chem 2022;10:1095598. [PMID: 36688039 DOI: 10.3389/fchem.2022.1095598] [Reference Citation Analysis]
9 Schmidt TJN, Berarducci B, Konstantinidou S, Raffa V. CRISPR/Cas9 in the era of nanomedicine and synthetic biology. Drug Discov Today 2023;28:103375. [PMID: 36174966 DOI: 10.1016/j.drudis.2022.103375] [Reference Citation Analysis]
10 Li J, Zhang H, Han Y, Hu Y, Geng Z, Su J. Targeted and responsive biomaterials in osteoarthritis. Theranostics 2023;13:931-54. [PMID: 36793867 DOI: 10.7150/thno.78639] [Reference Citation Analysis]
11 Molina BG, Vasani RB, Jarvis KL, Armelin E, Voelcker NH, Alemán C. Dual pH- and electro-responsive antibiotic-loaded polymeric platforms for effective bacterial detection and elimination. Reactive and Functional Polymers 2022;181:105434. [DOI: 10.1016/j.reactfunctpolym.2022.105434] [Reference Citation Analysis]
12 Xu XL, Xue Y, Ding JY, Zhu ZH, Wu XC, Song YJ, Cao YL, Tang LG, Ding DF, Xu JG. Nanodevices for deep cartilage penetration. Acta Biomater 2022;154:23-48. [PMID: 36243371 DOI: 10.1016/j.actbio.2022.10.007] [Reference Citation Analysis]
13 Ismail EA, Devnarain N, Govender T, Omolo CA. Stimuli-responsive and biomimetic delivery systems for sepsis and related complications. J Control Release 2022;352:1048-70. [PMID: 36372385 DOI: 10.1016/j.jconrel.2022.11.013] [Reference Citation Analysis]
14 Armenia I, Cuestas Ayllón C, Torres Herrero B, Bussolari F, Alfranca G, Grazú V, Martínez de la Fuente J. Photonic and magnetic materials for on-demand local drug delivery. Advanced Drug Delivery Reviews 2022;191:114584. [DOI: 10.1016/j.addr.2022.114584] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
15 Shree D, Patra CN, Sahoo BM. Novel Herbal Nanocarriers for Treatment of Dermatological Disorders. Pharm Nanotechnol 2022;10:246-56. [PMID: 35733305 DOI: 10.2174/2211738510666220622123019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Nazli A, He DL, Liao D, Khan MZI, Huang C, He Y. Strategies and progresses for enhancing targeted antibiotic delivery. Adv Drug Deliv Rev 2022;189:114502. [PMID: 35998828 DOI: 10.1016/j.addr.2022.114502] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Mohammadzadeh V, Norouzi A, Ghorbani M. Multifunctional nanocomposite based on lactose@layered double hydroxide-hydroxyapatite as a pH-sensitive system for targeted delivery of doxorubicin to liver cancer cells. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2022;651:129723. [DOI: 10.1016/j.colsurfa.2022.129723] [Reference Citation Analysis]
18 Yadav D, Wairagu PM, Kwak M, Jin JO. Nanoparticle-Based Inhalation Therapy for Pulmonary Diseases. Curr Drug Metab 2022;23:882-96. [PMID: 35927812 DOI: 10.2174/1389200223666220803103039] [Reference Citation Analysis]
19 Morales-Becerril A, Aranda-Lara L, Isaac-Olivé K, Ocampo-García BE, Morales-Ávila E. Nanocarriers for delivery of siRNA as gene silencing mediator. EXCLI J 2022;21:1028-52. [PMID: 36110562 DOI: 10.17179/excli2022-4975] [Reference Citation Analysis]
20 Dutta G, Manickam S, Sugumaran A. Stimuli-Responsive Hybrid Metal Nanocomposite - A Promising Technology for Effective Anticancer Therapy. Int J Pharm 2022;:121966. [PMID: 35764265 DOI: 10.1016/j.ijpharm.2022.121966] [Reference Citation Analysis]
21 Tella JO, Adekoya JA, Ajanaku KO. Mesoporous silica nanocarriers as drug delivery systems for anti-tubercular agents: a review. R Soc Open Sci 2022;9:220013. [PMID: 35706676 DOI: 10.1098/rsos.220013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Tie S, Xiang S, Chen Y, Qiao F, Cui W, Su W, Tan M. Facile synthesis of food-grade and size-controlled nanocarriers based on self-assembly of procyanidins and phycocyanin. Food Funct 2022;13:4023-31. [PMID: 35315469 DOI: 10.1039/d1fo04222j] [Reference Citation Analysis]
23 Wei X, Ji L, Peng J, Du K, Feng F. Noncovalent Engineering of Apoferritin with a PEGylated [FeFe] Hydrogenase Mimic for In Situ Polymerization. ACS Appl Bio Mater 2022. [PMID: 35323009 DOI: 10.1021/acsabm.2c00124] [Reference Citation Analysis]
24 Jain A, Mcginty S, Pontrelli G, Zhou L. Theoretical model for diffusion-reaction based drug delivery from a multilayer spherical capsule. International Journal of Heat and Mass Transfer 2022;183:122072. [DOI: 10.1016/j.ijheatmasstransfer.2021.122072] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
25 Yang X, Duan J, Wu L. Research advances in NQO1-responsive prodrugs and nanocarriers for cancer treatment. Future Med Chem 2022. [PMID: 35102756 DOI: 10.4155/fmc-2021-0289] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
26 Zhang M, Hu W, Cai C, Wu Y, Li J, Dong S. Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment. Materials Today Bio 2022. [DOI: 10.1016/j.mtbio.2022.100223] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
27 Karpuz M, İlhan M, Gültekin HE, Ozgenc E, Şenyiğit Z, Atlihan-gundogdu E. Nanovesicles for tumor-targeted drug delivery. Applications of Nanovesicular Drug Delivery 2022. [DOI: 10.1016/b978-0-323-91865-7.00017-1] [Reference Citation Analysis]
28 Malaiya A, Singhai M, Paliwal SR, Paliwal R. Basics of targeted nanodrug delivery of chemotherapeutics for breast cancer therapy. Targeted Nanomedicine for Breast Cancer Therapy 2022. [DOI: 10.1016/b978-0-12-824476-0.00017-6] [Reference Citation Analysis]
29 Sheshala R, Madheswaran T, Panneerselvam J, Vora L, Thakur RRS. Stimuli-responsive nanomaterials in infectious diseases. Nanotheranostics for Treatment and Diagnosis of Infectious Diseases 2022. [DOI: 10.1016/b978-0-323-91201-3.00005-0] [Reference Citation Analysis]
30 Kakoti BB, Deka K, Bezbaruah R, Sailo N. Multifunctional nanocarrier systems targeting brain tumors: A review. Nanocarriers for Drug-Targeting Brain Tumors 2022. [DOI: 10.1016/b978-0-323-90773-6.00029-4] [Reference Citation Analysis]
31 Judy E, Lopus M, Kishore N. Mechanistic insights into encapsulation and release of drugs in colloidal niosomal systems: biophysical aspects. RSC Adv 2021;11:35110-26. [PMID: 35493162 DOI: 10.1039/d1ra06057k] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
32 Navarro-Barreda D, Bedrina B, Galindo F, Miravet JF. Glutathione-responsive molecular nanoparticles from a dianionic bolaamphiphile and their use as carriers for targeted delivery. J Colloid Interface Sci 2021;608:2009-17. [PMID: 34752979 DOI: 10.1016/j.jcis.2021.10.142] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Majumder J, Minko T. Multifunctional Lipid-Based Nanoparticles for Codelivery of Anticancer Drugs and siRNA for Treatment of Non-Small Cell Lung Cancer with Different Level of Resistance and EGFR Mutations. Pharmaceutics 2021;13:1063. [PMID: 34371754 DOI: 10.3390/pharmaceutics13071063] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
34 Chang D, Ma Y, Xu X, Xie J, Ju S. Stimuli-Responsive Polymeric Nanoplatforms for Cancer Therapy. Front Bioeng Biotechnol 2021;9:707319. [PMID: 34249894 DOI: 10.3389/fbioe.2021.707319] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
35 Nayak PP, S. N, Narayanan A, Badekila AK, Kini S. Nanomedicine in Cancer Clinics: Are We There Yet? Curr Pathobiol Rep 2021;9:43-55. [DOI: 10.1007/s40139-021-00220-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
36 Bochicchio S, Lamberti G, Barba AA. Polymer-Lipid Pharmaceutical Nanocarriers: Innovations by New Formulations and Production Technologies. Pharmaceutics 2021;13:198. [PMID: 33540659 DOI: 10.3390/pharmaceutics13020198] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 6.5] [Reference Citation Analysis]
37 Douloudi M, Nikoli E, Katsika T, Vardavoulias M, Arkas M. Dendritic Polymers as Promising Additives for the Manufacturing of Hybrid Organoceramic Nanocomposites with Ameliorated Properties Suitable for an Extensive Diversity of Applications. Nanomaterials (Basel) 2020;11:E19. [PMID: 33374206 DOI: 10.3390/nano11010019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
38 Silva F, Cabral Campello MP, Paulo A. Radiolabeled Gold Nanoparticles for Imaging and Therapy of Cancer. Materials (Basel) 2020;14:E4. [PMID: 33375074 DOI: 10.3390/ma14010004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
39 Majumder J, Minko T. Targeted Nanotherapeutics for Respiratory Diseases: Cancer, Fibrosis, and Coronavirus. Adv Ther (Weinh) 2020;:2000203. [PMID: 33173809 DOI: 10.1002/adtp.202000203] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]